Alkermes Announces Positive Topline Results From ENLIGHTEN-Early Phase 3b Study of LYBALVI® in Patients Early in Illness - Kilgore News Herald

Submitted by Anonymous (not verified) on Tue, 02/08/2022 - 12:00

Alkermes Announces Positive Topline Results From ENLIGHTEN-Early Phase 3b Study of LYBALVI® in Patients Early in Illness  Kilgore News Herald